4/A

FORM 4/A SUBMISSION

Company: Outlook Therapeutics, Inc.
Filed: October 15, 2019
Period of Report: September 18, 2019
Accession Number: 0001209191-19-053184

View Document ↗ View on SEC.gov ↗